NT-proBNP is a more sensitive and specific biomarker for the prediction of future atrial fibrillation than for forthcoming onset of heart failure: results from the observational DIAST-CHF study
27 August 2017 (14:00 - 18:00)
Organised by:
Abstract
About the speaker

German Heart Centre Berlin, Berlin (Germany)
7 More presentations in this session
Access the full session
The Event
ESC Congress 2017
27 August 2017
14:00 CET
